Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
FEBS Letters|November 19, 2002
The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodiesD P Hanger, G M Gibb, R de Silva, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 2009
Insight, cognition and quality of life in Alzheimer's diseaseC S Hurt, S Banerjee, C Tunnard, et al.Biochemical Society Symposium|July 13, 2001
Neurofibrillary tangles and tau phosphorylationJ P Brion, B H Anderton, M Authelet, et al.The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.Genome|November 11, 1998
Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genesP C Shaw, A F Davies, K F Lau, et al.International Journal of Geriatric Psychiatry|September 28, 2010
Apathy and cortical atrophy in Alzheimer's diseaseC Tunnard, D Whitehead, C Hurt, et al.The British Journal of Psychiatry : the Journal of Mental Science|February 7, 2001
Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's diseaseN Tunstall, M J Owen, J Williams, et al.FEBS Letters|April 1, 1999
Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylationR Dayanandan, M Van Slegtenhorst, T G Mack, et al.British Journal of Pharmacology|June 1, 1988
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivoJ E Tateson, R W Randall, C H Reynolds, et al.Journal of Internal Medicine|January 3, 2013
An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairmentG Spulber, A Simmons, J-S Muehlboeck, et al.Pageof 16